Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents

Thumbnail Image

Date

2013

Authors

Lambert, Stephen B
Chuk, Lai-man R.
Nissen, Michael D.
Nolan, Terry
McVernon, Jodie
Booy, Robert
Heron, L
Richmond, Peter
Walls, Tony
Marshall, Helen

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley-Blackwell

Abstract

Objective: To evaluate the safety of CSL's split-virion inactivated trivalent 2009 Southern Hemisphere formulation influenza vaccine (TIV) in children. Methods: We enrolled 1992 healthy children into three groups: Cohorts A, ≥6 months to <3 years; B,

Description

Keywords

Keywords: antipyretic agent; ibuprofen; influenza vaccine; oral rehydration solution; paracetamol; adolescent; adult; anorexia; article; axilla temperature; child; diarrhea; drug formulation; drug safety; drug tolerability; febrile convulsion; female; fever; flu li Adverse events; Fever; Influenza vaccine; Paediatrics; Safety

Citation

URI

http://hdl.handle.net/1885/73744

Collections

ANU Research Publications

Source

Influenza and Other Respiratory Viruses

Type

Journal article

Book Title

Entity type

Access Statement

Open Access

License Rights

DOI

10.1111/irv.12107

Restricted until

Downloads

File
Description
01_Lambert_Safety_and_tolerability_of_a_2013.pdf (174.66 KB)

DSpace software copyright © 2002-2026 LYRASIS

abcd